AllianceBernstein
CELL

AllianceBernstein’s PhenomeX Inc. Common Stock CELL Stock Holding History

AllianceBernstein’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-89,400
Closed -$104K – 3293
2023
Q1 		$104K Hold
89,400
– – ﹤0.01% 3027
2022
Q4 		$240K Buy
89,400
+20,500
+30% +$54K ﹤0.01% 2949
2022
Q3 		$197K Buy
68,900
+9,000
+15% +$38.3K ﹤0.01% 3019
2022
Q2 		$298K Buy
59,900
+9,800
+20% +$51.3K ﹤0.01% 2884
2022
Q1 		$356K Sell
50,100
-66,100
-57% -$547K ﹤0.01% 2816
2021
Q4 		$2.11M Buy
116,200
+40,000
+52% +$863K ﹤0.01% 2114
2021
Q3 		$1.49M Buy
76,200
+20,000
+36% +$761K ﹤0.01% 2325
2021
Q2 		$2.52M Sell
56,200
-1,048,059
-95% -$48.6M ﹤0.01% 2051
2021
Q1 		$55.5M Buy
1,104,259
+771,040
+231% +$52.6M 0.02% 580
2020
Q4 		$29.8M Buy
333,219
+106,526
+47% +$8.96M 0.01% 737
2020
Q3 		$17.3M Buy
+226,693
New +$14.4M 0.01% 847

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein's CELL Position: Q2 2023 in Review

AllianceBernstein sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 89,400 shares — an estimated $104K sold.

AllianceBernstein first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $55.5M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • AllianceBernstein reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • AllianceBernstein sold 89,400 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $104K.
  • AllianceBernstein first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • AllianceBernstein's PhenomeX Inc. Common Stock position peaked at $55.5M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.